A detailed history of Ameriprise Financial Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Ameriprise Financial Inc holds 2,924,141 shares of LLY stock, worth $2.3 Billion. This represents 0.68% of its overall portfolio holdings.

Number of Shares
2,924,141
Previous 3,027,901 3.43%
Holding current value
$2.3 Billion
Previous $2.74 Billion 5.5%
% of portfolio
0.68%
Previous 0.75%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $80.1 Million - $99.6 Million
-103,760 Reduced 3.43%
2,924,141 $2.59 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $16.2 Million - $20.4 Million
22,392 Added 0.75%
3,027,901 $2.74 Billion
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $86.4 Million - $116 Million
-145,947 Reduced 4.63%
3,005,509 $2.34 Billion
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $274 Million - $323 Million
-521,762 Reduced 14.2%
3,151,456 $1.84 Billion
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $188 Million - $259 Million
-432,630 Reduced 10.54%
3,673,218 $1.97 Billion
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $342 Million - $458 Million
-976,284 Reduced 19.21%
4,105,848 $1.93 Billion
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $89.6 Million - $105 Million
-288,589 Reduced 5.37%
5,082,132 $1.75 Billion
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $300 Million - $350 Million
-932,998 Reduced 14.8%
5,370,721 $1.96 Billion
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $290 Million - $331 Million
-979,498 Reduced 13.45%
6,303,719 $2.04 Billion
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $326 Million - $383 Million
-1,168,986 Reduced 13.83%
7,283,217 $2.36 Billion
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $112 Million - $139 Million
476,150 Added 5.97%
8,452,203 $2.41 Billion
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $69.8 Million - $86.6 Million
-310,414 Reduced 3.75%
7,976,053 $2.19 Billion
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $99.1 Million - $122 Million
-447,123 Reduced 5.12%
8,286,467 $1.91 Billion
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $69.3 Million - $89.7 Million
383,933 Added 4.6%
8,733,590 $2 Billion
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $149 Million - $193 Million
908,748 Added 12.21%
8,349,657 $1.56 Billion
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $169 Million - $224 Million
1,297,007 Added 21.11%
7,440,909 $1.26 Billion
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $3.64 Million - $4.21 Million
24,901 Added 0.41%
6,143,902 $909 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $58.4 Million - $70.3 Million
428,375 Added 7.53%
6,119,001 $1 Billion
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $280 Million - $347 Million
2,352,012 Added 70.45%
5,690,626 $789 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $63.7 Million - $78.9 Million
596,014 Added 21.73%
3,338,614 $439 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $182 Million - $198 Million
-1,703,835 Reduced 38.32%
2,742,600 $307 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $70.6 Million - $82.4 Million
-637,273 Reduced 12.54%
4,446,435 $493 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $63.4 Million - $74.7 Million
-569,969 Reduced 10.08%
5,083,708 $660 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $45.4 Million - $50.9 Million
-428,671 Reduced 7.05%
5,653,677 $654 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $36.8 Million - $45.9 Million
-428,028 Reduced 6.57%
6,082,348 $653 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $71.9 Million - $82.5 Million
949,332 Added 17.07%
6,510,376 $556 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $186 Million - $220 Million
2,508,641 Added 82.19%
5,561,044 $430 Million
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $115 Million - $124 Million
1,408,715 Added 85.7%
3,052,403 $258 Million
Q3 2017

Nov 07, 2017

BUY
$77.07 - $85.54 $127 Million - $141 Million
1,643,688
1,643,688 $141 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $747B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.